These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 17377186)

  • 1. Factors contributing to cavitation after CT-guided percutaneous radiofrequency ablation for lung tumors.
    Okuma T; Matsuoka T; Yamamoto A; Oyama Y; Inoue K; Nakamura K; Inoue Y
    J Vasc Interv Radiol; 2007 Mar; 18(3):399-404. PubMed ID: 17377186
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frequency and risk factors of various complications after computed tomography-guided radiofrequency ablation of lung tumors.
    Okuma T; Matsuoka T; Yamamoto A; Oyama Y; Toyoshima M; Nakamura K; Inoue Y
    Cardiovasc Intervent Radiol; 2008; 31(1):122-30. PubMed ID: 17985181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extending indications for radiofrequency ablation of lung tumors through an intraoperative approach.
    Linden PA; Wee JO; Jaklitsch MT; Colson YL
    Ann Thorac Surg; 2008 Feb; 85(2):420-3. PubMed ID: 18222236
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Repeat radiofrequency ablation for local progression of lung tumors: does it have a role in local tumor control?
    Hiraki T; Mimura H; Gobara H; Sano Y; Fujiwara H; Date H; Kanazawa S
    J Vasc Interv Radiol; 2008 May; 19(5):706-11. PubMed ID: 18440459
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiofrequency ablation for the treatment of unresectable lung metastases in patients with colorectal cancer: a multicenter study in Japan.
    Yamakado K; Hase S; Matsuoka T; Tanigawa N; Nakatsuka A; Takaki H; Takao M; Inoue Y; Kanazawa S; Inoue Y; Sawada S; Kusunoki M; Takeda K
    J Vasc Interv Radiol; 2007 Mar; 18(3):393-8. PubMed ID: 17377185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Percutaneous radiofrequency thermal ablation of renal cell carcinoma: is it possible a day-hospital treatment?
    Carrafiello G; Laganà D; Ianniello A; Mangini M; Fontana F; Cotta E; Concollato L; Marconi A; Recaldini C; Dionigi G; Rovera F; Boni L; Cuffari S; Fugazzola C
    Int J Surg; 2008; 6 Suppl 1():S31-5. PubMed ID: 19200792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Needle tract seeding after radiofrequency ablation of hepatic tumors.
    Jaskolka JD; Asch MR; Kachura JR; Ho CS; Ossip M; Wong F; Sherman M; Grant DR; Greig PD; Gallinger S
    J Vasc Interv Radiol; 2005 Apr; 16(4):485-91. PubMed ID: 15802448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CT-guided radiofrequency heat ablation of malignant lung tumors.
    Schaefer O; Lohrmann C; Ghanem N; Langer M
    Med Sci Monit; 2003 Nov; 9(11):MT127-31. PubMed ID: 14586288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic factors influencing the development of an iatrogenic pneumothorax for computed tomography-guided radiofrequency ablation of upper renal tumor.
    Park BK; Kim CK
    Acta Radiol; 2008 Dec; 49(10):1200-6. PubMed ID: 19031183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiofrequency thermal ablation in the treatment of lung malignancies.
    Gadaleta C; Catino A; Mattioli V
    In Vivo; 2006; 20(6A):765-7. PubMed ID: 17203764
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiofrequency ablation for the treatment of stage I non-small cell lung cancer in high-risk patients.
    Pennathur A; Luketich JD; Abbas G; Chen M; Fernando HC; Gooding WE; Schuchert MJ; Gilbert S; Christie NA; Landreneau RJ
    J Thorac Cardiovasc Surg; 2007 Oct; 134(4):857-64. PubMed ID: 17903496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Image-guided radiofrequency ablation (RFA) of spinal tumors.
    Gevargez A; Groenemeyer DH
    Eur J Radiol; 2008 Feb; 65(2):246-52. PubMed ID: 17524585
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Percutaneous radiofrequency ablation with transarterial embolization is useful for treatment of stage 1 renal cell carcinoma with surgical risk: results at 2-year mean follow up.
    Arima K; Yamakado K; Kinbara H; Nakatsuka A; Takeda K; Sugimura Y
    Int J Urol; 2007 Jul; 14(7):585-90; discussion 590. PubMed ID: 17645597
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors involved in the development of pneumothorax during radiofrequency ablation of lung neoplasms.
    Nour-Eldin NE; Naguib NN; Saeed AS; Ackermann H; Lehnert T; Korkusuz H; Vogl TJ
    AJR Am J Roentgenol; 2009 Jul; 193(1):W43-8. PubMed ID: 19542382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recurrence-free survival after radiofrequency ablation of hepatocellular carcinoma. A registry report of the impact of risk factors on outcome.
    Zytoon AA; Ishii H; Murakami K; El-Kholy MR; Furuse J; El-Dorry A; El-Malah A
    Jpn J Clin Oncol; 2007 Sep; 37(9):658-72. PubMed ID: 17766723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simultaneous computed tomography-guided biopsy and radiofrequency ablation of solitary pulmonary malignancy in high-risk patients.
    Schneider T; Puderbach M; Kunz J; Bischof A; Giesel FL; Dienemann H; Herth FJ; Schnabel PA; Safi S; Hoffmann H; Heussel CP
    Respiration; 2012; 84(6):501-8. PubMed ID: 23037897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative survival analysis in patients with pulmonary metastases from nasopharyngeal carcinoma treated with radiofrequency ablation.
    Pan CC; Wu PH; Yu JR; Li W; Huang ZL; Wang JP; Zhao M
    Eur J Radiol; 2012 Apr; 81(4):e473-7. PubMed ID: 21700408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [CT-guided radiofrequency ablation of liver metastases from colorectal cancer].
    Mahnken AH; Bruners P; Tacke JA; Günther RW
    Dtsch Med Wochenschr; 2009 May; 134(19):976-80. PubMed ID: 19401962
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Percutaneous radiofrequency ablation of lung tumours: results in the mid-term.
    Ambrogi MC; Lucchi M; Dini P; Melfi F; Fontanini G; Faviana P; Fanucchi O; Mussi A
    Eur J Cardiothorac Surg; 2006 Jul; 30(1):177-83. PubMed ID: 16723242
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Percutaneous radiofrequency ablation for unresectable pulmonary metastases from renal cell carcinoma.
    Soga N; Yamakado K; Gohara H; Takaki H; Hiraki T; Yamada T; Arima K; Takeda K; Kanazawa S; Sugimura Y
    BJU Int; 2009 Sep; 104(6):790-4. PubMed ID: 19338555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.